BIOMAT Database Logo BIOMAT Database Logo

Linezolid: safety and efficacy monitoring. 2012

Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D016527 Drug Costs The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES). Cost, Drug,Costs, Drug,Drug Cost
D054908 Extensively Drug-Resistant Tuberculosis Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC. Tuberculosis, Extensively Drug-Resistant,Extremely Drug-Resistant Tuberculosis,Tuberculosis, Extremely Drug-Resistant,XDR-TB,Drug-Resistant Tuberculoses, Extensively,Drug-Resistant Tuberculoses, Extremely,Drug-Resistant Tuberculosis, Extensively,Drug-Resistant Tuberculosis, Extremely,Extensively Drug Resistant Tuberculosis,Extensively Drug-Resistant Tuberculoses,Extremely Drug Resistant Tuberculosis,Extremely Drug-Resistant Tuberculoses,Tuberculoses, Extensively Drug-Resistant,Tuberculoses, Extremely Drug-Resistant,Tuberculosis, Extensively Drug Resistant,Tuberculosis, Extremely Drug Resistant
D023303 Oxazolidinones Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. 1,3-Oxazolidin-2-one,Oxazolidin-2-one,Oxazolidinone,1,3-Oxazolidine-2-one,2-Oxazolidone,2-oxazolidinone,1,3 Oxazolidin 2 one,1,3 Oxazolidine 2 one,2 Oxazolidone,2 oxazolidinone,Oxazolidin 2 one

Related Publications

Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Linezolid: safety and efficacy in special populations.
May 2011, The Journal of antimicrobial chemotherapy,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Efficacy and safety of linezolid in liver transplant patients.
August 2011, Transplant infectious disease : an official journal of the Transplantation Society,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Efficacy and safety of linezolid in immunocompromised children with cancer.
October 2010, Pediatrics international : official journal of the Japan Pediatric Society,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Clinical efficacy and safety of linezolid in intensive care unit patients.
January 2023, Journal of intensive medicine,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Safety and efficacy of linezolid in 16 infants and children in Japan.
August 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
September 2011, The European respiratory journal,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
December 2000, International journal of antimicrobial agents,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Safety and tolerability of linezolid.
May 2003, The Journal of antimicrobial chemotherapy,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
January 2011, Japanese journal of infectious diseases,
Mathieu S Bolhuis, and Arianna D Pranger, and Jan-Willem C Alffenaar
Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.
October 2016, Acta neurochirurgica,
Copied contents to your clipboard!